Back
Northrop Grumman Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
51
NOC
Northrop Grumman
Last Price:
$502.21
Seasonality Move:
6.19%
Buy
56
BMRN
Biomarin Pharmaceutical
Last Price:
$62.05
Seasonality Move:
-2.99%
Buy
51
Northrop Grumman (NOC)
is a Buy
Is Northrop Grumman a Buy, Sell or Hold?
-
The current Northrop Grumman [NOC] share price is $504.45. The Score for NOC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NOC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $62.53. The Score for BMRN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NOC Stock Price Chart
What is Northrop Grumman's stock price today?
-
The Northrop Grumman share price today is $504.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOC is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $62.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
NOC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.69 | Buy |
Relative Strength Index (14 RSI): | 68.21 | Buy |
Chaikin Money Flow: | 844054 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (461.6 - 482.3) | Buy |
Bollinger Bands (100): | (479.13 - 528.01) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.97 | Sell |
Relative Strength Index (14 RSI): | 38.23 | Sell |
Chaikin Money Flow: | 730635 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.64 - 67.56) | Sell |
Bollinger Bands (100): | (62.38 - 77.6) | Sell |
NOC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 476.14 | Buy |
20-day SMA: | 470.34 | Buy |
50-day SMA: | 484.27 | Buy |
200-day SMA: | 482.43 | Buy |
8-day EMA: | 480.37 | Buy |
20-day EMA: | 475.35 | Buy |
50-day EMA: | 482.8 | Buy |
200-day EMA: | 484.58 | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.18 | Sell |
20-day SMA: | 65.52 | Sell |
50-day SMA: | 65.42 | Sell |
200-day SMA: | 77.1 | Sell |
8-day EMA: | 63.51 | Sell |
20-day EMA: | 64.87 | Sell |
50-day EMA: | 66.39 | Sell |
200-day EMA: | 75.12 | Sell |
Northrop Grumman Earnings Growth & NOC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.90 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.05 per share, and an increase next year of $1.76 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.
Northrop Grumman Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |